Egypt Respiratory Market Analysis


  • Type: Therapeutics Area
  • Published : June 2021
  • Region: Africa
  • Country: Egypt
  • Report ID : 4777

  • Format: PPT, PDF

Egypt Respiratory Diseases Drugs Market: Segmented by Drug Class (Short-Acting Beta2-Agonists, Long-Acting Beta2-Agonists, Inhaled Corticosteroids, Anticholinergics, Antihistamines, Vasodilators, Combination Drugs, Others), Drug Type (Branded and Generic drugs), Route of Administration (Oral, Parenteral and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)- Growth, Trends, and Forecasts (2019 – 2028)

Published Date: June, 2021

SKU: 4777 Categories: ,

Egypt’s Respiratory diseases drugs market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

In Egypt, in 2016, 84% of the total number of deaths were due to NCDs, with four groups of diseases accounting for about 60% of the total death. Out of these Chronic Respiratory Diseases accounted for about 4% of the total deaths. Among the top 10 sources for DALYs in Egypt, lower respiratory infections were placed 6th in 2019.

According to the statistics, Egyptians consumed 83 billion cigarettes in 2017-18, at a cost of 73 billion pounds ($4.6 billion), while the consumption of muassel reached 50,000 tons a year, costing 3 billion pounds ($191 million). Such extensive smoking is already known to be a risk factor for many other respiratory infections, including colds, influenza, pneumonia, and tuberculosis. This is likely to increase the demand for the respiratory disease treatment market in Egypt.

Market Drivers

The emergence of respiratory illness and other chronic diseases are driving the growth of higher-value prescription medicines in Egypt. Epidemiological studies by the WHO suggest that these diseases are the main causes of morbidity and mortality in Egypt.

Egypt’s evolving disease profile mirrors Western trends. One of the key drivers behind Egypt’s pharmaceutical market growth is the rapidly growing chronic disease burden that has accompanied the fast-growing aging population in Egypt. This age group is prone to respiratory diseases and will lead to rise in market demand for the illnesses.

A 2019  study showed that Egypt was among the top 10 countries whose population smokes all kinds of tobacco, with daily consumption of 280 million cigarettes in 2017-18. There will be a notable increase in the number of disability-adjusted life years (DALYs) for chronic diseases in Egypt from 2017 to 2030. For Chronic Respiratory Illnesses, the DALYs are expected to go up by 58%.

The effects of smoking on the respiratory system make it more likely that smokers contract these diseases, which could be more severe. Smoking is also associated with increased development of acute respiratory distress syndrome, a key complication for severe cases of COVID-19, among people with severe respiratory infections.

All these factors are eventually increasing the disease burden for respiratory illnesses in the country. The respiratory illness drug market is thus expected to grow in the coming years.

1. Respiratory Diseases Drug Market Overview………………………………
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Increasing smoking habits in the population
B. Rising Geriatric Population
C. Increase in no. of Comorbidities Due to Respiratory Illness
3. Major Respiratory Diseases
A. Asthma
C. Chronic Bronchitis
D. Emphysema
E. Acute Bronchitis
F. Cystic Fibrosis
4. Respiratory Diseases Drug Market Segmentation………………………………
A. Drug Class
I. Short-Acting Beta2-Agonists (SABA)
II. Long-Acting Beta2-Agonists (LABA)
III. Inhaled Corticosteroids (ICS)
IV. Anticholinergics
V. Antihistamines
VI. Vasodilators
VII. Combination Drugs
VIII. Others
B. Drug Type
I. Branded Drugs
II. Generic Drugs
C. By Route Of Administration
I. Oral
II. Parenteral
III. Others
D. Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies/ Drug Stores
III. Others
5. Respiratory Diseases Major Drugs Market Share………………………………
A. Key Findings
B. Market Analysis, Insights and Forecast – By Drug Type
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. AstraZeneca overview, Product & Services, Strategies & Financials
B. EVA Pharma overview, Product & Services, Strategies & Financials
C. Boehringer Ingelheim Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………
A. New Trends and Development of Respiratory diseases drug market
B. Future Opportunities
10. Conclusion

By Drug Class

The market for respiratory diseases can be segmented into Short-Acting Beta2-Agonists (SABA), Long-Acting Beta2-Agonists (LABA), Inhaled Corticosteroids (ICS), Anticholinergics, Antihistamines, Vasodilators, Combination Drugs, and Others

By Drug Type

By drug class, the market of respiratory drugs can be segmented into Branded and Generic drugs

Rationalizing prescriptions to reflect purchasing power, therefore, bodes well for generic drug makers

By Route of Administration

By route of administration, the respiratory drugs market can be segmented into oral, parenteral, and others

By Distribution Channel

By distribution channel, the market for respiratory diseases drugs in Egypt can be segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

Major Players

Egypt’s Respiratory diseases treatment market appears to be fragmented with the presence of several local and global companies including Boehringer Ingelheim, EIPICO, AstraZeneca, GSK, Pharco, Amoun, Eva Pharma, Pfizer, Hikma.

Domestic producers in Egypt mainly manufacture generic drugs. Although multinational drug makers operate in Egypt, the market is increasingly shifting in favor of generic medicines, thus favoring domestic production. Price is a major barrier to accessing healthcare in Egypt.


Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements